تخطي إلى المحتوى الرئيسي

coagulation factor XIII A chain

ال F13A1 gene provides instructions for making one part, the A subunit, of a protein called factor XIII. This protein is part of a group of related proteins called coagulation factors that are essential for normal blood clotting. They work together as part of the coagulation cascade, which is a series of chemical reactions that forms blood clots in response to injury. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair. Factor XIII acts at the end of the cascade to strengthen and stabilize newly formed clots, preventing further blood loss.

Normal function

ال F13A1 gene provides instructions for making one part, the A subunit, of a protein called factor XIII. This protein is part of a group of related proteins called coagulation factors that are essential for normal blood clotting. They work together as part of the coagulation cascade, which is a series of chemical reactions that forms blood clots in response to injury. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair. Factor XIII acts at the end of the cascade to strengthen and stabilize newly formed clots, preventing further blood loss.

Factor XIII in the bloodstream is made of two A subunits (produced from the F13A1 gene) and two B subunits (produced from the F13B gene). When a new blood clot forms, the A and B subunits separate from one another, and the A subunit is cut (cleaved) to produce the active form of factor XIII (factor XIIIa). The active protein links together molecules of fibrin, the material that forms the clot, which strengthens the clot and keeps other molecules from breaking it down.

Studies suggest that factor XIII has additional functions, although these are less well understood than its role in blood clotting. Specifically, factor XIII is likely involved in other aspects of wound healing, immune system function, maintaining pregnancy, bone formation, and the growth of new blood vessels (angiogenesis).

Conditions referring to this gene or chromosome

Other names

bA525O21.1 (coagulation factor XIII, A1 polypeptide)

coagulation factor XIII A chain precursor

coagulation factor XIII, A polypeptide

coagulation factor XIII, A1 polypeptide

coagulation factor XIIIa

F13A

factor XIIIa

fibrin stabilizing factor, A subunit

fibrinoligase

FSF, A subunit

protein-glutamine gamma-glutamyltransferase A chain

TGase

transglutaminase A chain

transglutaminase. plasma

Related patient information and medicines

اختبارات تخثر الدم

Patient information leaflet

اختبارات تخثر الدم

اختبارات تخثر الدم are used to diagnose and assess bleeding problems and to monitor people who take الوارفارين or other مضاد للتخثر medicines. You may be advi... These chemicals then react with other chemicals and proteins in the plasma, called clotting factors. There are 13 known clotting factors which are called by their Roman numbers - factor.

مضادات التخثر

Patient information leaflet

مضادات التخثر

How do anticoagulants work. Our blood has a complex system of chemicals in it, which, when activated, cause blood clots to form. These activated platelets and the damaged tissue release chemicals which react with other chemicals and proteins in the blood, called clotting factors. There are 13 known clotting factors which are called by their Roman.

متلازمة الأجسام المضادة للفوسفوليبيد

Patient information leaflet

متلازمة الأجسام المضادة للفوسفوليبيد

It is a disease that affects the blood and makes it more likely to clot than normal - a thrombophilia. The presence of the antiphospholipid antibodies causes the increased tendency of the blood to clot - they can trigger the coagulation cascade. The coagulation cascade is a chain reaction of events or chemical reactions that occur in the blood,.

تخثر الدم

Patient information leaflet

تخثر الدم

The body has a natural clotting process in the blood, which is altered in thrombophilia. تخثر الدم refers to a group of conditions where the جلطات الدم more easily than normal. The body has a natural clotting process in the bl... When a blood vessel is injured, the clotting process is triggered. It is a chain reaction of different chemicals.

مريء باريت

Patient information leaflet

مريء باريت

The coil then emits heat energy which destroys the abnormal cells. Nearby normal cells then multiply and replace the destroyed abnormal cells. Argon plasma coagulation This treatment uses a jet of argon gas, together with an electric current, to burn away dysplastic cells. Endoscopic mucosal resection (EMR) This is a procedure that is done via.

هل يمكنني تناول أبيكسابان وريبيلسوس معًا؟

Patient information leaflet

هل يمكنني تناول أبيكسابان وريبيلسوس معًا؟

There ... These two medicines work in different ways and do not typically interfere with how the other is absorbed, broken down, or removed from the body. Why this happens أبيكسابان هو an anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Rybelsus is a GLP-1 receptor agonist used for type 2 diabetes that mimics.

قراءة إضافية ومراجع

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.
  • 18 Aug 2020 | أحدث إصدار
  • 1 Aug 2015 | نُشر في الأصل

انضم إلى المحادثة

شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.

تنويه: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
أداة التحقق من أهلية لقاح الإنفلونزا

اسأل، شارك، تواصل.

تصفح المناقشات، اطرح الأسئلة، وشارك التجارب عبر مئات المواضيع الصحية.

اشترك في النشرة الإخبارية للمرضى

جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.